“…High‐mobility group box 1 was initially identified as a nuclear protein that regulates various transcriptional factors to stabilize the nucleosome 21, while extracellular HMGB1, which can be either passively released from necrotic cells or actively secreted by activated inflammatory cells and stressed cells 8, 22, is reported to modulate inflammation through its high affinity receptors on the surface of target cells, including the receptor for advanced glycation end products and toll‐like receptors 2 and 4 23, 24. There exist growing recognition and experimental evidence to support that HMGB1 plays a pivotal role not only in the diseases such as sepsis, autoimmune disease, acute hepatic necrosis, acute lung injury 25, 26, 27, 28 but also in various heart diseases, including myocardial infarction and ischaemia‐reperfusion injury, however, with no consensus on the function of HMGB1 on the pathogenesis of the diseases 9, 16, 29, 30, 31, 32, 33, 34.…”